| Metric | FY2020 | FY2019 | FY2018 |
|---|---|---|---|
| Revenue | $230.1M+92.0% | $119.9M+136.1% | $50.8M |
| Cost of revenue | $12.3M+115.0% | $5.7M+170.5% | $2.1M |
| Research and development | $23.2M+106.6% | $11.2M+48.9% | $7.5M |
| Sales and marketing | $251.9M+126.2% | $111.4M+115.5% | $51.7M |
| General and administrative | $42.3M+158.2% | $16.4M+9.4% | $15.0M |
| Total costs and expenses | $329.7M+127.9% | $144.7M+89.6% | $76.3M |
| Loss from operations | -$99.6M-301.2% | -$24.8M+2.8% | -$25.5M |
| Interest expense, net | -$1.3M+46.9% | -$2.5M-14.0% | -$2.2M |
| Other income (expense), net | -$21.4M-675.3% | $3.7M+8366.7% | -$45K |
| Loss before income taxes | -$122.3M-418.3% | -$23.6M+15.0% | -$27.8M |
| Provision for income taxes | $115K | $0 | $0 |
| Net loss | -$122.5M-418.8% | -$23.6M+15.0% | -$27.8M |
| Net loss per share attributable to common stockholders - basic and diluted (in dollars per share) | -$420.00-366.7% | -$90.00+25.0% | -$120.00 |
| Weighted average common shares outstanding - basic and diluted (in shares) | 294.55B+12.8% | 261.23B+10.7% | 236.04B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.